|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's Range||66.02 - 66.02|
|52 Week Range||66.02 - 66.02|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Haleon plc ("Haleon") (LSE:HLN)(NYSE:HLN) today announced that its wholly-owned subsidiary GSK Consumer Healthcare Capital US LLC (the "Issuer") is exercising its option to redeem the total outstanding aggregate principal amount of its Callable Floating Rate Senior Notes due 2024 (the "Notes") on March 24, 2023 (the "Redemption Date").
The GSK group posted an 18% rise in sales to £7.8bn over the third quarter.
Jay Powell sounded hawkish on the outlook for rate rises from the central bank.